WVE-N531 demonstrated statistically significant improvements in muscle biopsy measures and functional measures in patients ...
Clinical Trials Arena on MSN23h
Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback